Biography:
Dr. Qin is CSO of Kexing Biopharma, Shenzhen, China from 2020 and VP Biology of Gensci Biopharma, Changchun, China from 2016 to 2019. Before, Dr. Qin served as Principal Scientist of Allergan Inc., Irvine, California, USA from 2002 to 2015, and was employed as a Research Fellow at NIH, Bethesda, Maryland from 1998 to 2002. Dr. Qin received his PhD degree in Biochemistry in 1998 at the School of Medicine, Fukui University and Kobe University, Japan. Dr. Qin has a proven track record of scientific innovation with 55 peer-reviewed publications, 45 patents and 15 INDs.
Title : GB10, a best-in-class antibody fusion protein targeting VEGF/Ang-2, exhibits promising therapeutic efficacy for neovascular eye diseases